Baudax Bio Inc. (BXRX)

Fourth Quarter 2021 Reported; Major Expense Reductions Announced


Gregory AurandMedia Inquiries
Senior Healthcare Services & Medical Devices Analyst
March 17, 2022
Report ID: 24601
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Baudax Bio Inc.
Baudax Bio Inc.
Healthcare
Biotechnology
Ticker
BXRX
Current Price
$0.1488 6.29%
Market Cap
$3.0M
Price Target
Refer to Report
Volume
685.1K
52wk Range
$0.131 - $14.7
Related Research Reports
11/10/2022

Feeling the Pain; Focus on NMBs
Feeling the Pain; Focus on NMBs (BXRX)
9/21/2022

Curing a Deficiency
Curing a Deficiency (BXRX)
8/31/2022

Priced Common Offering; Reducing Price Target
Priced Common Offering; Reducing Price Target (BXRX)
8/23/2022

Notice of Patent Allowance For Claims Covering ANJESO
Notice of Patent Allowance For Claims Covering ANJESO (BXRX)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.